Glenmark Pharmaceuticals Limited (BOM: 532296)

India flag India · Delayed Price · Currency is INR
1,641.55
+19.15 (1.18%)
At close: Jan 7, 2025
Market Cap 459.37B
Revenue (ttm) 130.80B
Net Income (ttm) -8.75B
Shares Out n/a
EPS (ttm) -31.02
PE Ratio n/a
Forward PE n/a
Dividend 2.50 (0.15%)
Ex-Dividend Date Sep 13, 2024
Volume 3,997
Open 1,615.45
Previous Close 1,622.40
Day's Range 1,615.45 - 1,658.20
52-Week Range 766.65 - 1,830.05
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 7, 2025

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, cardiology, diabetic, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, drops, and respiratory/MDI/DPI/n... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 14,989
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532296
Full Company Profile

Financial Performance

Financial Statements

News

Pharma Sector Stocks: Torrent Pharma (+0.25%) rises; Glenmark (-2.29%), Aurobindo (-2.02%) decline

The pharma sector showed mixed trends during the session as of 12:15 AM. Torrent Pharma was the only gainer, rising ₹8.45 to ₹3,336.30 (+0.25%). Sun Pharma dipped ₹4.95 to ₹1,800.50 (-0.27%), and Dr. ...

26 days ago - Business Upturn

Motilal Oswal’s healthcare sector picks: Sun Pharma, IPCA, Mankind, Ajanta, and Glenmark

Motilal Oswal Financial Services has highlighted key stock recommendations in the healthcare sector, projecting strong growth potential for 2024. The focus includes prominent pharmaceutical companies ...

27 days ago - Business Upturn

Glenmark shares surge 4% following positive Phase 1 trial results for ISB 2001

Glenmark Pharmaceuticals saw its stock price rise by 4% after Ichnos Glenmark Innovation (IGI) announced promising Phase 1 clinical trial results for ISB 2001, a trispecific antibody designed to treat...

4 weeks ago - Business Upturn

HSBC cuts target price for Glenmark Pharma shares to Rs 1,600 after Q2 results

HSBC has maintained a 'Hold' rating on Glenmark Pharma while trimming its target price to ₹1,600

7 weeks ago - Business Upturn

Glenmark Pharmaceuticals Q2 FY25 Results: Revenue up 5.6% YoY to ₹3,433.80 crore, profit at ₹354.48 crore versus loss of ₹180.30 crore YoY

Glenmark Pharmaceuticals Ltd. reported a 5.6% year-on-year (YoY) increase in revenue from operations for Q2 FY25, reaching ₹3,433.80 crore compared to ₹3,207.38 crore in Q2 FY24. On a quarter-on-quart...

7 weeks ago - Business Upturn

Glenmark Pharma Q2 results: Check share price ahead of Q2 results

Glenmark Pharmaceuticals shares are currently trading at ₹1,553.60, marking an increase of 0.92% as the company gears up to release its second-quarter earnings. With a total market cap of ₹43,840.75 c...

7 weeks ago - Business Upturn

Stocks to Watch Today: Hindustan Aeronautics, Grasim, Hero MotoCorp, Muthoot Finance, Bharat Forge, Glenmark Pharma to announce Q2 results

Several companies are scheduled to announce their Q2 FY25 earnings today. The last traded price (LTP) from yesterday’s closing is provided below for each company, which could influence market reaction...

7 weeks ago - Business Upturn

Glenmark Pharmaceuticals Q2 FY25 Results: Shares fall over 3% ahead of earnings release

Glenmark Pharmaceuticals Ltd shares were trading 3.25% lower at ₹1,525.75 on the NSE as of 11:37 a.m. on November 13, 2024, as investors anticipated the company’s Q2 FY25 results. Expectations for Gle...

2 months ago - Business Upturn

Glenmark Pharma shares recover after 10% drop – Here’s what you need to know

Glenmark Pharmaceuticals shares experienced a sharp 10% plunge earlier today, trading at ₹1,634.7. However, the stock has started to show signs of recovery as of 9:29 AM, trading 1.18% lower at ₹1,614...

2 months ago - Business Upturn

Glenmark Life Sciences shares jump 3% following ‘Buy’ upgrade by Kotak

Glenmark Life Sciences witnessed a surge of 3.15% in its share price, reaching ₹967.95 as of 11:38 AM on October 28, 2024. The stock saw positive momentum following Kotak’s double upgrade, which moved...

2 months ago - Business Upturn